DEA Proposes to Reschedule Hemp-Derived Cannabinoids
By Michelle Bodian, Shawn Hauser, Shane Pennington
May 11, 2023
At a DEA supply chain conference last week, Terrance Boos, Section Chief, Drug and Chemical Evaluation Section, stated that the DEA will be releasing a rule to reschedule certain hemp-derived cannabinoids.